These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 3009966)

  • 41. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4.
    Knobler RL; Lampert PW; Oldstone MB
    Nature; 1982 Jul; 298(5871):279-80. PubMed ID: 6283382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A combination of mutations in the S1 part of the spike glycoprotein gene of coronavirus MHV-A59 abolishes demyelination.
    Fu L; Gonzales DM; Das Sarma J; Lavi E
    J Neurovirol; 2004 Feb; 10(1):41-51. PubMed ID: 14982727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pathogenicity of a Philippine isolate of Naegleria sp. in mice: effects of dose levels and routes of infection.
    Simeon EC; Natividad FF; Enriquez GL
    Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):598-606. PubMed ID: 2098923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1986; 91(3-4):247-56. PubMed ID: 3022679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease.
    Morris VL; Tieszer C; Mackinnon J; Percy D
    Virology; 1989 Mar; 169(1):127-36. PubMed ID: 2538027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of virus receptor-bearing endothelial cells of the blood-brain barrier in preventing the spread of mouse hepatitis virus-A59 into the central nervous system.
    Godfraind C; Havaux N; Holmes KV; Coutelier JP
    J Neurovirol; 1997 Dec; 3(6):428-34. PubMed ID: 9475114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathology of MHV-A59 infection in beta 2 microglobulin negative mice.
    Lavi E; Wang Q; Gombold J; Sutherland R; Paterson Y; Weiss S
    Adv Exp Med Biol; 1995; 380():179-81. PubMed ID: 8830476
    [No Abstract]   [Full Text] [Related]  

  • 48. Chronic central nervous system demyelination in mice after JHM virus infection.
    Stohlman SA; Weiner LP
    Neurology; 1981 Jan; 31(1):38-44. PubMed ID: 6256683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infection of the basal ganglia by a murine coronavirus.
    Fishman PS; Gass JS; Swoveland PT; Lavi E; Highkin MK; Weiss SR
    Science; 1985 Aug; 229(4716):877-9. PubMed ID: 2992088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo.
    Smith AL; Cardellichio CB; Winograd DF; de Souza MS; Barthold SW; Holmes KV
    J Infect Dis; 1991 Apr; 163(4):879-82. PubMed ID: 1849166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental studies on vertical infection of mice with Japanese encephalitis virus. II. Effect of inoculation route on placental and fetal infection.
    Fujisaki Y; Miura Y; Sugimori T; Morimoto T; Ino T
    Natl Inst Anim Health Q (Tokyo); 1977; 17(2):39-44. PubMed ID: 196221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular reservoirs for coronavirus infection of the brain in beta2-microglobulin knockout mice.
    Lavi E; Das Sarma J; Weiss SR
    Pathobiology; 1999; 67(2):75-83. PubMed ID: 10023135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathology of diarrhea due to mouse hepatitis virus in the infant mouse.
    Ishida T; Fujiwara K
    Jpn J Exp Med; 1979 Feb; 49(1):33-41. PubMed ID: 224229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenicity of different strains of Rift Valley fever virus in Swiss albino mice.
    Tomori O; Kasali O
    Br J Exp Pathol; 1979 Aug; 60(4):417-22. PubMed ID: 508592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Giant cell formation in the brain of suckling mice infected with mouse hepatitis virus, JHM strain.
    Goto N; Takahashi K; Huang KJ; Katami K; Fujiwara K
    Jpn J Exp Med; 1979 Jun; 49(3):169-77. PubMed ID: 226760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice.
    Godfraind C; Friedrich VL; Holmes KV; Dubois-Dalcq M
    J Cell Biol; 1989 Nov; 109(5):2405-16. PubMed ID: 2553746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.
    Sorensen O; Dugre R; Percy D; Dales S
    Infect Immun; 1982 Sep; 37(3):1248-60. PubMed ID: 6290393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization.
    Lavi E; Gilden DH; Highkin MK; Weiss SR
    J Virol; 1984 Aug; 51(2):563-6. PubMed ID: 6086966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes.
    Hirano N; Murakami T; Taguchi F; Fujiwara K; Matumoto M
    Arch Virol; 1981; 70(1):69-73. PubMed ID: 6277284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. JHM infections in rats as a model for acute and subacute demyelinating disease.
    Wege H; Koga M; Wege H; ter Meulen V
    Adv Exp Med Biol; 1981; 142():327-40. PubMed ID: 6278889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.